Literature DB >> 24836063

Time to abandon over-simplified surrogates of ocular perfusion pressure in glaucoma research.

Anthony P Khawaja1, David P Crabb, Nomdo M Jansonius.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24836063      PMCID: PMC4441278          DOI: 10.1111/aos.12431

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
Editor The role of ocular perfusion pressure (OPP) in the pathogenesis of glaucoma has attracted a great deal of research interest, as highlighted in a review article recently published in Acta Ophthalmologica (Costa et al. 2013). For the majority of studies in this field, blood pressure (BP) minus intraocular pressure (IOP) has been used as a simple surrogate measure of OPP. The authors of the review article correctly acknowledge that interpretation of these surrogate measures is problematic and that any crude association observed between OPP and glaucoma may be related solely to the IOP component, given the known strength of IOP as a risk factor for glaucoma. However, we strongly disagree with the authors’ conclusion that statistically adjusting for IOP is a satisfactory solution to this problem. We have previously shown that it is quite impossible to untangle the effects of IOP and BP in a model containing OPP results (Khawaja et al. 2013). In short, adjusting for IOP in a model containing OPP will inevitably result in the situation that the coefficients for OPP actually represent the effect of BP only, and not OPP. This has been substantiated theoretically and demonstrated clearly using a simulated dataset; the coefficients for OPP in IOP adjusted regression models were exactly the same as those for BP in IOP adjusted models (Khawaja et al. 2013). Therefore, in studies that have found a significant association between OPP and glaucoma using regression models adjusted for IOP, it is actually a significant association between BP and glaucoma that has been demonstrated, and no conclusions can be drawn regarding perfusion pressure. OPP may well be important in glaucoma pathogenesis, but unfortunately the surrogate approach of calculating BP minus IOP is over-simplified, and results have been consistently misinterpreted, which has not furthered our understanding of the disease process. Given the critical issues highlighted, we strongly suggest abandoning the approach of assuming that BP minus IOP reflects OPP and that research resources are directed towards new methods in this important field.
  1 in total

1.  The role of ocular perfusion pressure in glaucoma cannot be studied with multivariable regression analysis applied to surrogates.

Authors:  Anthony P Khawaja; David P Crabb; Nomdo M Jansonius
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-07-10       Impact factor: 4.799

  1 in total
  2 in total

Review 1.  Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma.

Authors:  James R Tribble; Flora Hui; Melissa Jöe; Katharina Bell; Vicki Chrysostomou; Jonathan G Crowston; Pete A Williams
Journal:  Cells       Date:  2021-02-01       Impact factor: 6.600

2.  Genetic correlations between intraocular pressure, blood pressure and primary open-angle glaucoma: a multi-cohort analysis.

Authors:  Hugues Aschard; Jae H Kang; Adriana I Iglesias; Pirro Hysi; Jessica N Cooke Bailey; Anthony P Khawaja; R Rand Allingham; Allison Ashley-Koch; Richard K Lee; Sayoko E Moroi; Murray H Brilliant; Gadi Wollstein; Joel S Schuman; John H Fingert; Donald L Budenz; Tony Realini; Terry Gaasterland; William K Scott; Kuldev Singh; Arthur J Sit; Robert P Igo; Yeunjoo E Song; Lisa Hark; Robert Ritch; Douglas J Rhee; Vikas Gulati; Shane Haven; Douglas Vollrath; Donald J Zack; Felipe Medeiros; Robert N Weinreb; Ching-Yu Cheng; Daniel I Chasman; William G Christen; Margaret A Pericak-Vance; Yutao Liu; Peter Kraft; Julia E Richards; Bernard A Rosner; Michael A Hauser; Caroline C W Klaver; Cornelia M vanDuijn; Jonathan Haines; Janey L Wiggs; Louis R Pasquale
Journal:  Eur J Hum Genet       Date:  2017-08-30       Impact factor: 5.351

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.